What exactly did Cowen say in the BSX analyst rating on Feb 02, 2026?

Cowen reiterated a **Buy** rating on Boston Scientific (BSX) on February 02, 2026 at 09:41 AM, with no new price target disclosed. The note signals continued analyst confidence but not a fresh catalyst.

Does a maintained Buy change how I should trade BSX now?

A maintained Buy is not a clear trading trigger. Use the BSX analyst rating as confirmation of existing conviction and prioritize earnings, regulatory news, and procedure trends for trade decisions.

How does the BSX analyst rating affect long-term investors?

Long-term investors can view a maintained Buy as supportive but not decisive. The BSX analyst rating keeps the stock in buy consideration while investors monitor fundamentals and company guidance.

Where can I track future BSX analyst rating changes?

Track Cowen notes and broader coverage via news outlets like StreetInsider and Investing.com, and follow real-time updates on Meyka AI’s BSX stock page for consolidated analyst coverage.

Analyst Ratings

Cowen Maintains Buy on Boston Scientific (BSX) Feb 02, 2026

ByHuzaifa Zahoor February 3, 2026February 3, 2026

Cowen & Co. maintained a Buy rating on Boston Scientific Corporation (BSX) on February 02, 2026 at 09:41 AM. The move is a reiteration, not a change, and keeps Cowen aligned with a positive view of the company. The latest BSX analyst rating note came via StreetInsider and shows limited immediate conviction shift despite short-term selling pressure of -1.32% ($-1.22). Investors should read this as continued analyst confidence rather than a fresh catalyst.